Abstract
Typhoid fever is systemic illness caused by Salmonella enterica serovar Typhi (S. Typhi) in humans. Increasing multidrug resistant strains of S. Typhi and limited effect of available vaccines has necessitated exploring of new immunogens for protection against it. Earlier studies have shown that a crude preparation of outer membrane proteins (OMPs) of S. Typhi evokes strong immune response and induces a protective immunity against infection caused by diverse Gram-negative bacteria. In the present study we have evaluated the protective effect of a purified recombinant 49 kDa (r49kDa) OMP of S. Typhi alone or along with alum or complete Freund’s adjuvant, against a challenge by S. Typhi (0.4 × 50% lethal dose) by biochemical estimation of serum enzymes and oxidative stress enzymes in Swiss albino mice. There was a decrease in activity of alanine aminotransferase by 14.28%, 38.09%, 23.80%; aspartate aminotransferase by 6.25%, 25%, 16.25%; lipid peroxidation by 4.34%, 18.84%, 11.59%; and catalase by 8%, 14%, 10%, respectively, whereas increase in activity of reduced glutathione by 33.33%, 61.11%, 44.44%; glutathione peroxidase by 7%, 16%, 10%; and glutathione reductase by 8%, 20%, 12%, respectively, as compared to control animals challenged with bacteria without pre-immunization. The results indicated that immunization of mice with r49kDa OMP alone or in combination with adjuvants protected and normalized the liver. It reduces the development of oxidative stress in mice against Salmonella infection and the risk of getting typhoid. These results represent an additional supplement to our earlier reported data on protective immunity evoked by this protein.
Similar content being viewed by others
Abbreviations
- ALT:
-
alanine aminotransferase
- AST:
-
aspartate aminotransferase
- CAT:
-
catalase
- CFA:
-
complete Freund’s adjuvant
- GPX:
-
glutathione peroxidase
- GR:
-
glutathione reductase
- GSH:
-
reduced glutathione
- IEC:
-
intestinal epithelial cell
- IFA:
-
incomplete Freund’s adjuvant
- LD50:
-
lethal dose 50%
- LPO:
-
lipid peroxidation
- MDA:
-
malondialdehyde
- MDR:
-
multidrug-resistant
- OMP:
-
outer membrane protein
- PMS:
-
post mitochondrial supernatant
- r49kDa:
-
recombinant 49 kDa
- S. Typhi:
-
Salmonella enterica serovar Typhi
- TCA:
-
trichloroacetic acid
References
Abro A.H., Abdou A.M.S., Gangwani J.L., Ustadi A.M., Younis N.J. & Hussaini H.S. 2009. Hematological and biochemical changes in typhoid fever. Pak. J. Med. Sci. 25: 166–171.
Akinyemi K., Smith S., Oyefolu A. & Coker A. 2005. Multidrug resistance in Salmonella enterica serovar typhi isolated from patients with typhoid fever complications in Lagos, Nigeria. Public Health 119: 321–7.
Allam U.S., Krishna M.G., Lahiri A., Joy O. & Chakravortty D. 2011. Salmonella enterica serovar Typhimurium lacking hfq gene confers protective immunity against murine typhoid. PLoS ONE 6: e16667.
Anand L., Brajachand N.G. & Dhanachand C.H. 1996. Cryptosporidiosis in HIV infection. J. Commun. Dis. 28: 241–244.
Asahi M., Fujji J., Takao T., Kuzuya T., Hori M., Shimonishi Y. & Taniguchi N. 1997. The oxidation of selenocysteine is involved in the inactivation of glutathione peroxidase by nitric oxide donor. J. Biol. Chem. 272: 19152–19157.
Ayhan A., Gokoz A., Karacadag S. & Telatar H. 1973. The liver in typhoid fever. Am. J. Gastroenterol. 59: 141–146.
Bhunia R., Hutin Y., Ramakrishnan R., Pal N., Sen T. & Murhekar M. 2009. A typhoid fever outbreak in a slum of South Dumdum Municipality, West Bengal, India, 2007: evidence for foodborne and waterborne transmission. BMC Public Health 9: 115.
Blanco F., Isibasi A., Gonzalez C.R., Ortiz V., Paniagua J., Arregnin C. & Kumate J. 1993. Human cell mediated immunity to porins from Salmonella typhi. Scand. J. Infect. Dis. 25: 73–80.
Briviba K., Kissner R., Konnenol W.H. & Sies H. 1998. Kinetic study of the reaction of glutathione peroxide with peroxynitrite. Chem. Res. Toxicol. 11: 1398–1401.
Chatfield S.N., Dorman C.J., Hayward C. & Dougan G. 1991. Role of ompR dependent genes in Salmonella typhimurium virulence: mutants deficient in both ompC and ompF are attenuated in vivo. Infect. Immun. 59: 449–452.
Cheminay C. & Hensel M. 2008. Rational design of Salmonella recombinant vaccines. Int. J. Med. Microbiol. 298: 87–98.
Claiborne A. 1985. Catalase activity, pp. 283–284. In: Greenwald R.A. (ed.), Handbook of Methods for Oxygen Radical Research, CRC Press, Boca Raton, FL.
Crump J.A. & Mintz E.D. 2010. Global trends in typhoid and paratyphoid fever. Clin. Infect. Dis. 50: 241–246.
Dougan G., John V., Palmer S. & Mastroeni P. 2011. Immunity to salmonellosis. Immunol. Rev. 240: 196–210.
Dringen R., Pawlowski P.G. & Hirrlinger J. 2005. Peroxide detoxification by brain cells. J. Neurosci. Res. 79: 157–165.
Finn G.J. & Condon S. 1975. Regulation of catalase synthesis in Salmonella typhimurium. J. Bacteriol. 123: 570–579.
Garmony H.S., Brown K.B. & Titball R.W. 2002. atSalmonella vaccines for use in humans: present and future perspectives. FEMS Microbiol. Rev. 26: 339–353.
Godinez I., Haneda T., Raffatellu M., George M.D., Paixao T.A., Rolan H.G., Santos R.L., Dandekar S., Tsolis R.M. & Baumler A.J. 2008. T cells help to amplify inflammatory responses induced by Salmonella enterica serotype Typhimurium in the intestinal mucosa. Infect. Immun. 76: 2008–2017.
González-Quintela A., Campos J., Alende R., Lopez-Soto A., Tome S., Otero E. & Torre J.A. 2004. Abnormalities in liver enzyme levels during Salmonella enteritidis enterocolitis. Rev. Esp. Enferm. Dig. 96: 559–566.
Huang G.C., Chang C.M., Ko W.C., Huang Y.L. & Chuang Y.C. 2005. Typhoid fever complicated by multiple organ involvement: report of two cases. J. Infect. 51: e57–e60.
Hamid N. & Jain S.K. 2008. Characterization of an outer membrane protein of Salmonella enterica serovar typhimurium that confers protection against typhoid. Clin. Vaccine Immunol. 15: 1461–1471.
Hamid N. & Jain S.K 2010. Immunogenic evaluation of a recombinant 49-kilodalton outer membrane protein of Salmonella typhi as a candidate for a subunit vaccine against typhoid. J. Infect. Dis. Immun. 2: 30–40.
Ho Y.S., Xiong Y., Ma W., Spector A. & Ho D.S. 2004. Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J. Biol. Chem. 279: 32804–32812.
Ivanoff B., Levine M.M. & Lambert P.H. 1994. Vaccination against typhoid fever: present status. Bull. World Health Organ. 72: 957–971.
Jollow D.J., Mitchell J.R., Zampaglione M. & Gillete J.R. 1974. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzene as the hepatotoxic intermediate. Pharmacol. 11: 151–169.
Kaur J. & Jain S.K. 2012. Role of antigens and virulence factors of Salmonella enterica serovar Typhi in its pathogenesis. Microbiol. Res. 167: 199–210.
Keitel W.A., Bond N.L., Zahradnik J.M., Cramton T.A. & Robbins J.B. 1994. Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines. Vaccine 12: 195–199.
Khan K.H. 2009. Terminalia chebula reduces the oxidative stress induced by Salmonella typhimurium in mice and may reduce the risk of getting typhoid. Advan. Biol. Res. 3: 1–8.
Khosla S.N., Singh R., Singh G.P. & Trehan VK 1988. The spectrum of hepatic injury in enteric fever. Am. J. Gastroenterol. 83: 413–416.
Kidd P.M. 1997. Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines. Alt. Med. Review 2: 155–176.
Klotz S.A., Jorgensen J.H., Buckwold F.J. & Craven P.C. 1984. Typhoid fever. An epidemic with remarkably few clinical signs and symptoms. Arch. Intern. Med. 144: 533–537.
Kussi N., Nurminen M. & Sravas M. 1981. Immunochemical characterization of major outer membrane components from Salmonella typhimurium. Infect. Immun. 33: 750–757.
Levine M.M., Ferreccio C., Abrego P., Martin O.S., Ortiz E. & Cryz S. 1999. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine 17: S22–S27.
Liang-Takasaki C., Saxen H., Makela H. & Lieve L. 1983. Compement activation by polysaccharide and lipopolysaccharide: an important virulence determinant of salmonellae. Infect. Immun. 41: 563–569.
Lowry O.H., Rosenbrough N.J., Farr A.L. & Randall R.J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265–268.
Majowicz S.E., Musto J., Scallan E., Angulo F.J., Kirk M., O’Brien S.J., Jones T.F., Fazil A. & Hoekstra R.M. 2010. The global burden of non typhoidal Salmonella gastroenteritis. Clin. Infect. Dis. 50: 882–889.
Mastroeni P. & Menager N. 2003. Development of acquired immunity to salmonella. Med. Microbiol. 52: 453–459.
Merican I. 1997. Typhoid fever: present and future. Med. J. Malaysia 52: 299–308; quiz 309.
Mirsadraee M., Shirdel A. & Roknee F. 2007. Typhoid myopathy or typhoid hepatitis: a matter of debate. Indian J. Med. Microbiol. 25: 351–353.
Mohandas J., Marshall J.J., Duggin G.G., Horvath J.S. & Tiller D. 1984. Differential distribution of glutathione and glutathione related enzymes in rabbit kidney: possible interactions in analgesic neuropathy. Cancer Res. 44: 5086–5091.
Morgenstern R. & Hayes P.C. 1991. The liver in typhoid: always affected, not just a complication. Am. J. Gastroenterol. 86: 1235–1239.
Muthukkumar S. & Muthukkaruppan V.R. 1993. Mechanism of protective immunity induced by porin-lipopolysaccharide against murine salmonellosis. Infect. Immun. 61: 3017–3025.
Ochiai R.L., Acosta C.J., Danovaro-Holliday M.C., Baiqing D., Bhattacharya S.K., Agtini M.D., Bhutta Z.A., Canh do G., Ali M., Shin S., Wain J., Page A.L., Albert M.J., Farrar J., Abu-Elyazeed R., Pang T., Galindo C.M., von Seidlein L. & Clemens J.D. 2008. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull. World Health Organ. 86: 260–268.
Ohkawa H., Ohishi N. & Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 9: 351–358.
Ortiz V., Isibasi A., Garcia-Ortigoza E. & Kumate J. 1989. Immunoblot detection of class-specific humoral immune response to outer membrane proteins isolated from Salmonella typhi in humans with typhoid fever. J. Clin. Microbiol. 27: 1640–1645.
Ramachandran S., Godfrey J.J. & Perera M.V.F. 1974. Typhoid hepatitis. JAMA 230: 236–240.
Recknagel R.O., Glende E.A., Jr Dolak J.A. & Waller R.L. 1991. Mechanisms of carbon tetrachloride toxicity. Pharmacol. Therap. 43: 139–54.
Reed J. & Muench H. 1938. A simple method for estimating the fifty percent end points. Am. J. Hyg. 27: 493–497.
Reitman S. & Frankel S. 1957. A colorometric method for the determination of serum glutanic oxaloautic and glutamic pyruvic transaminases. Amer. J. Clin. Pathol. 28: 56–63.
Retornaz F., Fournier P.E., Seux V., Jacomo V. & Soubeyrand J. 1999. A case of Salmonella enteritidis septicemia complicated by disseminated intravascular coagulation, severe hepatitis, rhabdomyolisis and acute renal failure. Eur. J. Clin. Microbiol. Infect. Dis. 18: 830–841.
Rosenthal M.D. & Glew R.H. 2009. Medical Biochemistry: HumanMetabolism in Health and Disease. John Wiley and Sons, Hoboken, NJ.
Shetty A.K., Mital S.R., Bahrainwala A.H., Khubchandani R.P. & Kumta N.B. 1999. Typhoid hepatitis in children. J. Trop. Pediatr. 45: 287–290.
Simonsen R. & Uirji M.A. 1984. Interpreting the profile of liver-function tests in pediatric liver transplants. Clin. Chem. 30: 1607–1610.
Vaca C.E., Wilhelm J. & Harms-Ringdahl M. 1988. Studies on lipid peroxidation in rat liver nuclei and isolated nuclear membranes. Biochim. Biophys. Acta 958: 375–387.
Verdugo-Roudriguez A., Gam L.H. & Devi S. 1993. Detection of antibodies against Salmonella typhi outer membrane protein preparation in typhoid fever patients. Asian Pac. J. Allergy Immunol. 11: 45–52.
Williams A.T. & Burk R.F. 1990. Carbon tetrachloride heaptotoxicity: an example of free radical-mediated injury. Sem. Liver Dis. 10: 279–284.
Wright J.R., Colby H.D. & Miles P.R. 1981. Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch. Biochem. Biophys. 206: 296–304.
Yang B., Qu D., Zhang X., Shen J., Cui S., Shi Y., Xi M., Sheng M., Zhi S. & Meng J. 2010. Prevalence and characterization of Salmonella serovars in retail meats of marketplace in Shaanxi, China. Int. J. Food. Microbiol. 141: 63–72.
Zhang X.L., Jeza V.T. & Pan Q. 2008. Salmonella typhi: from a human pathogen to a vaccine vector. Cell Mol. Immunol. 5: 91–97.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaur, J., Jain, S.K. Protection against experimental salmonellosis by recombinant 49 kDa OMP of Salmonella enterica serovar Typhi: biochemical aspects. Biologia 68, 194–201 (2013). https://doi.org/10.2478/s11756-013-0160-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11756-013-0160-z